Trials / Conditions / Stage IIIA Uterine Corpus Cancer

Stage IIIA Uterine Corpus Cancer

10 registered clinical trials studyying Stage IIIA Uterine Corpus Cancer.

Status	Trial	Sponsor	Phase
Completed	Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partn NCT03112668	Rutgers, The State University of New Jersey	N/A
Completed	Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors NCT03198286	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	N/A
Completed	Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed NCT02501954	Women's Cancer Care Associates, LLC	Phase 3
Terminated	Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC- NCT02112552	Albert Einstein College of Medicine	Phase 2
Completed	Physical Activity Behavioral Intervention in Obese Endometrial Cancer Survivors NCT02575872	Albert Einstein College of Medicine	N/A
Completed	Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors NCT01522820	Roswell Park Cancer Institute	Phase 1
Completed	Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Isl NCT01010126	National Cancer Institute (NCI)	Phase 2
Terminated	Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer NCT01041027	Albert Einstein College of Medicine	Phase 2
Completed	Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persi NCT00729586	National Cancer Institute (NCI)	Phase 2
Completed	Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV En NCT00575952	Gynecologic Oncology Group	Phase 1